business
Nuvalent Catapults To Record High On GSK's $10.6 Billion All-Cash Bid
Nuvalent Catapults To Record High On GSK's $10.6 Billion All-Cash Bid
Read full story on Yahoo Finance → More top storiesAlso covered by
Bloomberg Markets
GSK Agrees to Buy Nuvalent for $10.6 Billion
DW English
World conflicts hit record high in 2025: report
Al Jazeera
Nuclear weapons spending surges to record high of $119bn, report says
CNBC
UK's GSK to acquire U.S. drugmaker Nuvalent for $10.6 billion as pharma giants race to expand pipelines
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop